Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effects of Medium-term Oral Guanidinoacetic Acid (GAA) Administration on Human Performance, Body Composition, and Metabolic Outcomes in Physically Active Men and Women

NCT01133899 is registered in ClinicalTrials.gov with Metropolitan University, Serbia as lead sponsor.

NCT NCT01133899
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01133899 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effects of Medium-term Oral Guanidinoacetic Acid (GAA) Administration on Human Performance, Body Composition, and Metabolic Outcomes in Physically Active Men and Women
Lead sponsor
Metropolitan University, Serbia
Phase
Phase 1/2
Overall status
Completed
Start date
March 31, 2010
Completion date
December 31, 2011
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

athletic performance